AI solution for prognosis of COVID-19 pneumonia Therapanacea develops AI solution to quantify the severity of lung damage from COVID-19 Oct. 12, 2020 By Bernard Banga No Comments PARIS – A consortium that includes Therapanacea SAS, GE Healthcare France SAS, Orange Healthcare SA, the AP-HP group of 39 hospitals in the Paris region and the French academic society for thoracic imaging has created a database for COVID-19.Read More